Bauder-Wüst U - Search Results

1

Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617.

Dos Santos JC, Schäfer M, Bauder-Wüst U, Beijer B, Eder M, Leotta K, Kleist C, Meyer JP, Dilling TR, Lewis JS, Kratochwil C, Kopka K, Haberkorn U, Mier W. Dos Santos JC, et al. Among authors: bauder wust u. Front Chem. 2022 Aug 9;10:898692. doi: 10.3389/fchem.2022.898692. eCollection 2022. Front Chem. 2022. PMID: 36017165 Free PMC article.

2

Alkylating benzamides with melanoma cytotoxicity.

Wolf M, Bauder-Wüst U, Mohammed A, Schönsiegel F, Mier W, Haberkorn U, Eisenhut M. Wolf M, et al. Melanoma Res. 2004 Oct;14(5):353-60. doi: 10.1097/00008390-200410000-00004. Melanoma Res. 2004. PMID: 15457090

3

Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction.

Wolf M, Bauder-Wüst U, Haberkorn U, Mier W, Eisenhut M. Wolf M, et al. Melanoma Res. 2005 Oct;15(5):383-91. doi: 10.1097/00008390-200510000-00006. Melanoma Res. 2005. PMID: 16179865

4

Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.

Wolf M, Eskerski H, Bauder-Wüst U, Haberkorn U, Eisenhut M. Wolf M, et al. Melanoma Res. 2006 Dec;16(6):487-96. doi: 10.1097/01.cmr.0000232294.14408.6a. Melanoma Res. 2006. PMID: 17119449

5

Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.

Wolf M, Hull WE, Mier W, Heiland S, Bauder-Wüst U, Kinscherf R, Haberkorn U, Eisenhut M. Wolf M, et al. J Med Chem. 2007 Jan 11;50(1):139-48. doi: 10.1021/jm061003a. J Med Chem. 2007. PMID: 17201417

6

Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275.

Altmann A, Eisenhut M, Bauder-Wüst U, Markert A, Askoxylakis V, Hess-Stumpp H, Haberkorn U. Altmann A, et al. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2286-97. doi: 10.1007/s00259-010-1573-3. Epub 2010 Aug 3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20680269

7

Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.

Kubas H, Schäfer M, Bauder-Wüst U, Eder M, Oltmanns D, Haberkorn U, Mier W, Eisenhut M. Kubas H, et al. Nucl Med Biol. 2010 Nov;37(8):885-91. doi: 10.1016/j.nucmedbio.2010.06.005. Epub 2010 Jul 24. Nucl Med Biol. 2010. PMID: 21055618

8

Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression.

Hennrich U, Seyler L, Schäfer M, Bauder-Wüst U, Eisenhut M, Semmler W, Bäuerle T. Hennrich U, et al. Bioorg Med Chem. 2012 Feb 15;20(4):1502-10. doi: 10.1016/j.bmc.2011.12.052. Epub 2012 Jan 2. Bioorg Med Chem. 2012. PMID: 22264762

9

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

Eder M, Schäfer M, Bauder-Wüst U, Hull WE, Wängler C, Mier W, Haberkorn U, Eisenhut M. Eder M, et al. Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13. Bioconjug Chem. 2012. PMID: 22369515

10

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.

Schäfer M, Bauder-Wüst U, Leotta K, Zoller F, Mier W, Haberkorn U, Eisenhut M, Eder M. Schäfer M, et al. EJNMMI Res. 2012 Jun 6;2(1):23. doi: 10.1186/2191-219X-2-23. EJNMMI Res. 2012. PMID: 22673157 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page